Vivencio Barrios

7.8k total citations
353 papers, 4.1k citations indexed

About

Vivencio Barrios is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Vivencio Barrios has authored 353 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 267 papers in Cardiology and Cardiovascular Medicine, 108 papers in Surgery and 71 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Vivencio Barrios's work include Blood Pressure and Hypertension Studies (131 papers), Atrial Fibrillation Management and Outcomes (59 papers) and Lipoproteins and Cardiovascular Health (54 papers). Vivencio Barrios is often cited by papers focused on Blood Pressure and Hypertension Studies (131 papers), Atrial Fibrillation Management and Outcomes (59 papers) and Lipoproteins and Cardiovascular Health (54 papers). Vivencio Barrios collaborates with scholars based in Spain, Germany and United States. Vivencio Barrios's co-authors include Carlos Escobar, Alberto Calderón, J.L. Llisterri, Carlos Escobar, Mariano de la Figuera, Carlos Escobar, Luís M. Ruilope, José Ramón González‐Juanatey, Diego González-Segura Alsina and J.A. Divisón and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Journal of the American College of Cardiology.

In The Last Decade

Vivencio Barrios

314 papers receiving 3.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Vivencio Barrios 2.7k 905 902 421 400 353 4.1k
Maria Carla Roncaglioni 1.5k 0.6× 813 0.9× 798 0.9× 196 0.5× 306 0.8× 101 3.8k
Vicente Bertoméu 2.6k 1.0× 498 0.6× 891 1.0× 237 0.6× 260 0.7× 243 3.5k
Jean‐Pierre Boissel 1.7k 0.6× 458 0.5× 513 0.6× 168 0.4× 394 1.0× 53 2.9k
Mátyás Keltai 5.3k 2.0× 1.5k 1.6× 1.8k 1.9× 289 0.7× 900 2.3× 71 7.0k
Steen Z. Abildstrøm 4.1k 1.5× 675 0.7× 1.3k 1.4× 421 1.0× 455 1.1× 110 6.7k
Shelly Sapp 3.4k 1.3× 269 0.3× 2.1k 2.3× 252 0.6× 518 1.3× 56 7.1k
Dave L. Dixon 1.3k 0.5× 782 0.9× 977 1.1× 359 0.9× 105 0.3× 151 3.7k
Daniel E. Hilleman 1.1k 0.4× 434 0.5× 638 0.7× 186 0.4× 182 0.5× 147 3.3k
John Goudevenos 3.1k 1.1× 723 0.8× 1.6k 1.8× 129 0.3× 416 1.0× 194 6.3k
Joan Sala 2.4k 0.9× 924 1.0× 1.0k 1.1× 374 0.9× 116 0.3× 122 4.3k

Countries citing papers authored by Vivencio Barrios

Since Specialization
Citations

This map shows the geographic impact of Vivencio Barrios's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivencio Barrios with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivencio Barrios more than expected).

Fields of papers citing papers by Vivencio Barrios

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivencio Barrios. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivencio Barrios. The network helps show where Vivencio Barrios may publish in the future.

Co-authorship network of co-authors of Vivencio Barrios

This figure shows the co-authorship network connecting the top 25 collaborators of Vivencio Barrios. A scholar is included among the top collaborators of Vivencio Barrios based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivencio Barrios. Vivencio Barrios is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cinza‐Sanjurjo, Sergio, et al.. (2024). Achievement of LDL‐Cholesterol Goals in Patients Receiving LLT in Primary Care: TERESA‐AP Study. Cardiovascular Therapeutics. 2024(1). 4227941–4227941. 1 indexed citations
2.
Padial, Luis Rodrı́guez, et al.. (2024). Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial. Endocrinología Diabetes y Nutrición (English ed ). 71(7). 278–289.
3.
4.
Barrios, Vivencio, Eduardo Barge‐Caballero, Carlos Escobar, et al.. (2023). Situación actual del abordaje integral de la insuficiencia cardiaca en España. Proyecto OPTIMISE-IC. REC CardioClinics. 58(4). 289–302.
5.
Fácila, Lorenzo, et al.. (2023). Nuevas tecnologías para el diagnóstico, tratamiento y seguimiento de las enfermedades cardiovasculares. Revista Española de Cardiología. 77(1). 88–96. 4 indexed citations
6.
Díez‐Villanueva, Pablo, et al.. (2023). Use of Direct Acting Oral Anticoagulants in Elderly Patients with Atrial Fibrillation: A Multicenter, Cross-Sectional Study in Spain. Journal of Clinical Medicine. 12(3). 1224–1224. 5 indexed citations
7.
Zatarain‐Nicolás, Eduardo, Pilar Martı́n, Iván Márquez‐Rodas, et al.. (2023). Cardiovascular toxicity of checkpoint inhibitors: review of associated toxicity and design of the Spanish Immunotherapy Registry of Cardiovascular Toxicity. Clinical & Translational Oncology. 25(11). 3073–3085. 4 indexed citations
8.
Barrios, Vivencio, et al.. (2022). Conocimiento del cardiólogo clínico sobre diabetes mellitus tipo 2 de alto riesgo. ¿Qué sabemos y cómo podemos mejorar?. REC CardioClinics. 57(4). 263–270. 1 indexed citations
9.
Barrios, Vivencio, Sergio Cinza‐Sanjurjo, Javier García‐Alegría, et al.. (2022). Role of Telemedicine in the Management of Oral Anticoagulation in Atrial Fibrillation: A Practical Clinical Approach. Future Cardiology. 18(9). 743–754. 7 indexed citations
10.
González‐Juanatey, Carlos, Manuel Anguita‐Sánchez, Vivencio Barrios, et al.. (2022). Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing. Journal of Clinical Medicine. 11(20). 6004–6004. 8 indexed citations
11.
Barrios, Vivencio, Carlos Escobar, Manuel Anguita, et al.. (2021). Recommendations to improve lipid control in primary prevention patients. A consensus document of the Spanish Society of Cardiology. REC CardioClinics. 56(3). 208–217. 3 indexed citations
12.
Barrios, Vivencio, Carlos Escobar, Manuel Anguita, et al.. (2021). Recomendaciones para mejorar el control lipídico en pacientes en prevención primaria. Documento de consenso de la Sociedad Española de Cardiología. REC CardioClinics. 56(2). 118–128. 3 indexed citations
13.
Pallarés‐Carratalá, Vicente, et al.. (2021). Posicionamiento SEMERGEN en el abordaje de la insuficiencia cardíaca crónica en atención primaria. Medicina de Familia SEMERGEN. 48(2). 106–123. 4 indexed citations
14.
Arribas, Fernando, Vivencio Barrios, Julio Martí‐Almor, et al.. (2020). Chronic Coronary Syndrome: Overcoming Clinical Practice Guidelines. The role of the COMPASS Strategy. Current Cardiology Reviews. 17(3). 294–305. 3 indexed citations
15.
Barrios, Vivencio, José Polo García, Carlos Escobar, et al.. (2016). Evaluation of SAMe-TT 2 R 2 score and other clinical factors influencing the quality of anticoagulation therapy in non-valvular atrial fibrillation: a nationwide study in Spain. Current Medical Research and Opinion. 32(7). 1201–1207. 21 indexed citations
16.
Barrios, Vivencio, et al.. (2010). ANTIHYPERTENSIVE EFFICACY AND TOLERABILITY OFLERCANIDIPINE IN DAILY CLINICAL PRACTICE. THE ELYPSE STUDY. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Lorgelly, Paula, Andrew Briggs, Hans Wedel, et al.. (2009). An Economic Evaluation of Rosuvastatin Treatment in Systolic Heart Failure: Evidence from the CORONA Trial. European Journal of Heart Failure. 12(1). 66–74. 14 indexed citations
18.
Barrios, Vivencio, et al.. (2008). Correction. Heart. 94(7). 935.4–935. 2 indexed citations
19.
Barrios, Vivencio, et al.. (2008). Correction. Heart. 94(7). 935.3–935. 2 indexed citations
20.
Barrios, Vivencio, et al.. (2008). Prevalence of left ventricular hypertrophy detected by Cornell voltage‐duration product in a hypertensive population. Blood Pressure. 17(2). 110–115. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Carla Roncaglioni Breakdown of academic impact, for papers by Vicente Bertoméu Breakdown of academic impact, for papers by Jean‐Pierre Boissel Breakdown of academic impact, for papers by Mátyás Keltai Breakdown of academic impact, for papers by Steen Z. Abildstrøm Breakdown of academic impact, for papers by Shelly Sapp Breakdown of academic impact, for papers by Dave L. Dixon Breakdown of academic impact, for papers by Daniel E. Hilleman Breakdown of academic impact, for papers by John Goudevenos Breakdown of academic impact, for papers by Joan Sala
Rankless by CCL
2026